Q4 2024 Revenues, Gross Margin and EPS All Surpassed Guidance Range Issued on November 7, 2024Company Q1 2025 Guidance: Revenues…
Sanofi: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025 Paris,…
2024 business growth in line with guidance Revenues up +5% to €41.2mOrder book at end-2024: €21.7m Bezons (France), January 29,…
Management expects 2024 fourth quarter revenue of approximately $3.0 million and full year 2024 of approximately $8.6 million, representing growth…
Streamlined organization and Provider Services segment to optimize resource allocationProvider Services focus on Home Health/Hospice, Personal Care, Rehabilitation Services, and…
January 13, 2025 02:08 ET | Source: Telix Pharmaceuticals Limited MELBOURNE, Australia and INDIANAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) --…
MILWAUKEE, Dec. 10, 2024 (GLOBE NEWSWIRE) -- LeaseCrunch LLC, a leading lease accounting software company, announces the upcoming webinar “2025…
December 05, 2024 08:00 ET | Source: Theriva Biologics, Inc. ROCKVILLE, Md., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics…
Ad hoc announcement pursuant to Art. 53 LR Mid-term sales guidance upgraded to +6% CAGR 2023-2028 and +5% 2024-2029Strong momentum…
Total Company Revenue increased 14.7% to $461.1 million in the third quarter of 2024 from $402.0 million in the third…